Skip to Content
Merck
CN

Engineered bacteria detect tumor DNA.

Science (New York, N.Y.) (2023-08-10)
Robert M Cooper, Josephine A Wright, Jia Q Ng, Jarrad M Goyne, Nobumi Suzuki, Young K Lee, Mari Ichinose, Georgette Radford, Feargal J Ryan, Shalni Kumar, Elaine M Thomas, Laura Vrbanac, Rob Knight, Susan L Woods, Daniel L Worthley, Jeff Hasty
ABSTRACT

Synthetic biology has developed sophisticated cellular biosensors to detect and respond to human disease. However, biosensors have not yet been engineered to detect specific extracellular DNA sequences and mutations. Here, we engineered naturally competent Acinetobacter baylyi to detect donor DNA from the genomes of colorectal cancer (CRC) cells, organoids, and tumors. We characterized the functionality of the biosensors in vitro with coculture assays and then validated them in vivo with sensor bacteria delivered to mice harboring colorectal tumors. We observed horizontal gene transfer from the tumor to the sensor bacteria in our mouse model of CRC. This cellular assay for targeted, CRISPR-discriminated horizontal gene transfer (CATCH) enables the biodetection of specific cell-free DNA.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Dihexadecyldimethylammonium bromide, 97%
Sigma-Aldrich
GSK-3 Inhibitor XVI, GSK-3 Inhibitor XVI - CAS 252917-06-9, is a cell-permeable, potent, ATP-competitive, and highly selective GSK-3 inhibitor (IC₅₀ = 10 and 6.7 nM against GSK-3α and GSK-3β, respectively).